<DOC>
	<DOCNO>NCT01752725</DOCNO>
	<brief_summary>The aim study evaluation efficiency safety new , CE-certified thermofu-sion dissection instrument BiCision® comparison long establish Ultracision® Har-monic Scalpel ( Ethicon ) laparoscopic supracervical hysterectomy ( LASH ) .</brief_summary>
	<brief_title>Comparison BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy ( LASH )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>age &gt; 18 gender : female indication laparoscopic supracervical hysterectomy adnexectomyor surgery capability comply study requirement sign informed consent Invasive malignome pelvis Cardiac pacemaker implant defibrilator information available compatibility RF energy Abnormal blood parameter ( value less factor 0.8 1.25 compare value creatinine standard hemogram ) Abnormal coagulation parameter : PTT &gt; 40 sec . / Quick'sValue &lt; 50 % ( use antiplateletsup max . 100mg/d exclusion criterion ) Inability understand purpose study status laparotomy longitudinal incision intraabdominal adhesion ( begin surgery ≥ 5 section adhesiolysis ) open laparoscopy require different anatomical situation yield different surgery requirement conspicuous PAP , cervixmyoma endometriosis rectovaginale space</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>supracervical hysterectomy</keyword>
	<keyword>vessel seal</keyword>
	<keyword>bipolar electrocoagulation</keyword>
</DOC>